Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Endorecherche claims EM-800 for estrogen-dependent disorders

Oct. 11, 1996

Schering AG's tubulin polymerization inhibitors for cancer

Oct. 11, 1996

Daiichi claims new taxol derivatives

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...